Pharma – Asia, MENA, ROW Regulatory News – June 2025
BRAZIL
Anvisa Warns About Very Rare Adverse Event Associated With Semaglutide That Can Lead to Vision Loss
Anvisa has issued a warning about a very rare but serious side effect—sudden vision...
Asia Pharma News, Drug Regulatory News, Global Pharma Guidelines, June 2025 Pharma Updates, MENA Pharma Regulations, Pharma Industry Trends, Pharma regulatory updates, Pharmaceutical Compliance, Regulatory Changes Pharma, ROW Pharma Compliance